BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17488484)

  • 1. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
    Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
    Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
    Mrózek K; Marcucci G; Paschka P; Bloomfield CD
    Curr Opin Oncol; 2008 Nov; 20(6):711-8. PubMed ID: 18841055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CNA on AML prognosis.
    Gonzales F; Cheok MH
    Oncotarget; 2018 Feb; 9(16):12540-12541. PubMed ID: 29560083
    [No Abstract]   [Full Text] [Related]  

  • 4. The challenge of risk stratification in acute myeloid leukemia with normal karyotype.
    Zaidi SZ; Owaidah T; Al Sharif F; Ahmed SY; Chaudhri N; Aljurf M
    Hematol Oncol Stem Cell Ther; 2008; 1(3):141-58. PubMed ID: 20063545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of FLT3 Variations Associated with Structural and Functional Impact on Acute Myeloid Leukemia: A Computational Study.
    Mirza Z; Al-Saedi DA; Alganmi N; Karim S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2.
    Chen X; Yang S; Zeng J; Chen M
    Mol Med Rep; 2019 Jan; 19(1):508-514. PubMed ID: 30483794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia.
    McGill CM; Brown TJ; Cheng YY; Fisher LN; Shanmugavelandy SS; Gustafson SJ; Dunlap KL; Lila MA; Kester M; Toran PT; Claxton DF; Barth BM
    Int J Biopharm Sci; 2018 Jan; 1(1):. PubMed ID: 29607443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients.
    Shafik RE; Hassan NM; El Meligui YM; Shafik HE
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):609-613. PubMed ID: 28440611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation.
    Barth BM; Keasey NR; Wang X; Shanmugavelandy SS; Rampal R; Hricik T; Cabot MC; Kester M; Wang HG; Shultz LD; Tallman MS; Levine RL; Loughran TP; Claxton DF
    J Leuk (Los Angel); 2014 Sep; 2(3):. PubMed ID: 28239612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.
    Kelly AD; Kroeger H; Yamazaki J; Taby R; Neumann F; Yu S; Lee JT; Patel B; Li Y; He R; Liang S; Lu Y; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Jelinek J; Issa JP
    Leukemia; 2017 Oct; 31(10):2011-2019. PubMed ID: 28074068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.
    Strati P; Kantarjian H; Ravandi F; Nazha A; Borthakur G; Daver N; Kadia T; Estrov Z; Garcia-Manero G; Konopleva M; Rajkhowa T; Durand M; Andreeff M; Levis M; Cortes J
    Am J Hematol; 2015 Apr; 90(4):276-81. PubMed ID: 25530214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant Enrichment with 3'-Modified Oligonucleotides (MEMO)-Quantitative PCR for Detection of NPM1 Mutations in Acute Myeloid Leukemia.
    Shin SY; Ki CS; Kim HJ; Kim JW; Kim SH; Lee ST
    J Clin Lab Anal; 2015 Sep; 29(5):361-5. PubMed ID: 25384962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results.
    Hemmat M; Chen W; Anguiano A; Naggar ME; Racke FK; Jones D; Wang Y; Strom CM; Chang K; Boyar FZ
    Mol Cytogenet; 2014; 7():35. PubMed ID: 25177364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia.
    Sabnis H; Bradley HL; Bunting ST; Cooper TM; Bunting KD
    J Transl Med; 2014 Jun; 12():166. PubMed ID: 24923301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia.
    Pierceall WE; Kornblau SM; Carlson NE; Huang X; Blake N; Lena R; Elashoff M; Konopleva M; Cardone MH; Andreeff M
    Mol Cancer Ther; 2013 Dec; 12(12):2940-9. PubMed ID: 24092807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia.
    Meng CY; Noor PJ; Ismail A; Ahid MF; Zakaria Z
    Int J Biomed Sci; 2013 Mar; 9(1):26-32. PubMed ID: 23675286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of MN1 sequences necessary for myeloid transformation.
    Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
    PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
    Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
    Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Daver N; Strati P; Jabbour E; Kadia T; Luthra R; Wang S; Patel K; Ravandi F; Cortes J; Qin Dong X; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2013 Jan; 88(1):56-9. PubMed ID: 23115106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.
    de la Blétière DR; Blanchet O; Cornillet-Lefèbvre P; Coutolleau A; Baranger L; Geneviève F; Luquet I; Hunault-Berger M; Beucher A; Schmidt-Tanguy A; Zandecki M; Delneste Y; Ifrah N; Guardiola P
    BMC Med Genomics; 2012 Jan; 5():6. PubMed ID: 22289410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.